telmisartan has been researched along with Peripheral Arterial Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazzano, L; Criqui, MH; Domanchuk, K; Ferrucci, L; Guralnik, JM; Kibbe, MR; Kosmac, K; Leeuwenburgh, C; Lloyd-Jones, D; McDermott, MM; Peterson, CA; Polonsky, TS; Sufit, R; Tian, L; Zhang, D; Zhao, L | 1 |
| Beckman, JA; Bonaca, MP; Hess, C | 1 |
| Böhm, M; Lonn, EM; Mahfoud, F; Mancia, G; Mann, JFE; Marx, N; Redon, J; Schmieder, RE; Schumacher, H; Sliwa, K; Teo, KK; Weber, MA; Williams, B; Yusuf, S | 1 |
| Andrassy, M; Blessing, E; Ivandic, B; Katus, HA; Krumsdorf, U; Tiefenbacher, CP; Volz, HC; Zankl, AR | 1 |
3 trial(s) available for telmisartan and Peripheral Arterial Diseases
| Article | Year |
|---|---|
Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease: The TELEX Randomized Clinical Trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Double-Blind Method; Exercise Test; Exercise Therapy; Female; Humans; Lower Extremity; Male; Middle Aged; Peripheral Arterial Disease; Telmisartan; Walking | 2022 |
Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Determination; Cardiovascular Diseases; Case-Control Studies; Diabetes Mellitus; Diastole; Drug Therapy, Combination; Heart Failure; Hospitalization; Humans; Hypertension; Myocardial Infarction; Peripheral Arterial Disease; Ramipril; Retrospective Studies; Risk Factors; Stroke; Systole; Telmisartan | 2019 |
Telmisartan improves absolute walking distance and endothelial function in patients with peripheral artery disease.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Ankle Brachial Index; Benzimidazoles; Benzoates; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Peripheral Arterial Disease; Prospective Studies; Quality of Life; Single-Blind Method; Telmisartan; Treatment Outcome; Vasodilation; Walking | 2010 |
1 other study(ies) available for telmisartan and Peripheral Arterial Diseases
| Article | Year |
|---|---|
Telmisartan and Walking Performance in Peripheral Artery Disease.
Topics: Cardiovascular Agents; Humans; Peripheral Arterial Disease; Telmisartan; Walking | 2022 |